Pentameric CRP was suggested to upregulate the activation of DNA binding protein complex NF-κB, a key mediator of atherosclerosis [42–44] and the expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells. Here, CRP is linked to atherosclerosis.